Skip to Content

WATSON 425 (Aspirin, Butalbital, Caffeine and Codeine Phosphate 325 mg / 50 mg / 40 mg / 30 mg)

Pill with imprint WATSON 425 is Blue & Yellow, Capsule-shape and has been identified as Aspirin, Butalbital, Caffeine and Codeine Phosphate 325 mg / 50 mg / 40 mg / 30 mg. It is supplied by Watson Pharmaceuticals.

Aspirin/butalbital/caffeine/codeine is used in the treatment of headache and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Aspirin/butalbital/caffeine/codeine 325 mg / 50 mg / 40 mg / 30 mg is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for WATSON 425

Aspirin, butalbital, caffeine and codeine phosphate 325 mg / 50 mg / 40 mg / 30 mg WATSON 425

Aspirin, Butalbital, Caffeine and Codeine Phosphate

Imprint
WATSON 425
Strength
325 mg / 50 mg / 40 mg / 30 mg
Color
Blue & Yellow
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Watson Pharmaceuticals
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Related Images for "WATSON 425"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.